Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Guidelines for menopausal hormone therapy: Recommendations of the Polish Menopause and Andropause Society - state of knowledge as of December 2013.

Bińkowska M, Dębski R, Paszkowski T, Sendrakowska M, Zgliczyński W.

Prz Menopauzalny. 2014 Mar;13(1):1-12. doi: 10.5114/pm.2014.41078. No abstract available.

2.

Long-term consequences of estrogens administered in midlife on female cognitive aging.

Daniel JM, Witty CF, Rodgers SP.

Horm Behav. 2015 Aug;74:77-85. doi: 10.1016/j.yhbeh.2015.04.012. Epub 2015 Apr 25. Review.

3.

The role of leptin in regulating bone metabolism.

Upadhyay J, Farr OM, Mantzoros CS.

Metabolism. 2015 Jan;64(1):105-13. doi: 10.1016/j.metabol.2014.10.021. Epub 2014 Oct 25. Review.

4.

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY; Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF).

Osteoporos Int. 2013 Jan;24(1):23-57. doi: 10.1007/s00198-012-2074-y. Epub 2012 Oct 19.

5.

If you don't take it - it can't work: the consequences of not being treated or nonadherence to osteoporosis therapy.

Adachi JD, Josse RG, Russell RG.

Ther Clin Risk Manag. 2011;7:181-98. doi: 10.2147/TCRM.S17513. Epub 2011 May 24.

6.

Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis.

Jönsson B, Ström O, Eisman JA, Papaioannou A, Siris ES, Tosteson A, Kanis JA.

Osteoporos Int. 2011 Mar;22(3):967-82. doi: 10.1007/s00198-010-1424-x. Epub 2010 Oct 9.

7.

Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club.

Body JJ, Bergmann P, Boonen S, Boutsen Y, Devogelaer JP, Goemaere S, Kaufman JM, Rozenberg S, Reginster JY.

Osteoporos Int. 2010 Oct;21(10):1657-80. doi: 10.1007/s00198-010-1223-4. Epub 2010 May 18.

8.
9.

Estrogen regulation of apoptosis in osteoblasts.

Bradford PG, Gerace KV, Roland RL, Chrzan BG.

Physiol Behav. 2010 Feb 9;99(2):181-5. doi: 10.1016/j.physbeh.2009.04.025. Epub 2009 May 5.

10.

Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis.

Sare GM, Gray LJ, Bath PM.

Eur Heart J. 2008 Aug;29(16):2031-41. doi: 10.1093/eurheartj/ehn299. Epub 2008 Jul 3. Review.

11.

Bone mass is preserved and cancellous architecture altered due to cyclic loading of the mouse tibia after orchidectomy.

Fritton JC, Myers ER, Wright TM, van der Meulen MC.

J Bone Miner Res. 2008 May;23(5):663-71. doi: 10.1359/jbmr.080104.

12.

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, Rizzoli R; European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).

Osteoporos Int. 2008 Apr;19(4):399-428. doi: 10.1007/s00198-008-0560-z. Epub 2008 Feb 12. Review. Erratum in: Osteoporos Int. 2008 Jul;19(7): 1103-4..

13.

Issues concerning the use of hormone replacement therapy and risk of fracture: a population-based, nested case-control study.

Corrao G, Zambon A, Nicotra F, Conti V, Nappi RE, Merlino L.

Br J Clin Pharmacol. 2008 Jan;65(1):123-9. Epub 2007 Oct 22.

Supplemental Content

Support Center